Susquehanna International Group’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.02M Sell
890,500
-463,600
-34% -$7.32M ﹤0.01% 3458
2025
Q4
$24.7M Buy
1,354,100
+408,200
+43% +$6.88M ﹤0.01% 2003
2025
Q3
$13.9M Buy
945,900
+147,200
+18% +$2.52M ﹤0.01% 2593
2025
Q2
$14.5M Buy
798,700
+345,300
+76% +$7.04M ﹤0.01% 2376
2025
Q1
$9M Sell
453,400
-233,500
-34% -$4.04M ﹤0.01% 2672
2024
Q4
$11.8M Buy
686,900
+643,600
+1,486% +$12.1M ﹤0.01% 2460
2024
Q3
$866K Buy
43,300
+33,300
+333% +$518K ﹤0.01% 7143
2024
Q2
$112K Buy
+10,000
New +$83.9K ﹤0.01% 10941
2023
Q4
Sell
-18,700
Closed -$66.9K 12255
2023
Q3
$66.9K Sell
18,700
-13,800
-42% -$53.1K ﹤0.01% 11153
2023
Q2
$120K Sell
32,500
-2,700
-8% -$10K ﹤0.01% 10797
2023
Q1
$117K Sell
35,200
-29,900
-46% -$103K ﹤0.01% 11159
2022
Q4
$253K Sell
65,100
-29,900
-31% -$92.2K ﹤0.01% 9521
2022
Q3
$231K Buy
95,000
+16,600
+21% +$39.8K ﹤0.01% 10470
2022
Q2
$155K Sell
78,400
-24,400
-24% -$48K ﹤0.01% 10980
2022
Q1
$188K Sell
102,800
-326,900
-76% -$510K ﹤0.01% 11304
2021
Q4
$606K Buy
429,700
+67,900
+19% +$89.3K ﹤0.01% 8650
2021
Q3
$409K Sell
361,800
-107,300
-23% -$150K ﹤0.01% 9877
2021
Q2
$751K Sell
469,100
-22,900
-5% -$40.3K ﹤0.01% 8555
2021
Q1
$866K Buy
492,000
+287,700
+141% +$658K ﹤0.01% 8099
2020
Q4
$398K Buy
204,300
+16,700
+9% +$35.1K ﹤0.01% 8736
2020
Q3
$448K Buy
187,600
+145,000
+340% +$398K ﹤0.01% 7897
2020
Q2
$125K Sell
42,600
-1,100
-3% -$3.16K ﹤0.01% 9378
2020
Q1
$126K Buy
43,700
+31,300
+252% +$108K ﹤0.01% 9148
2019
Q4
$50K Sell
12,400
-12,600
-50% -$54.9K ﹤0.01% 9341
2019
Q3
$111K Buy
25,000
+1,800
+8% +$7.52K ﹤0.01% 9504
2019
Q2
$90K Buy
+23,200
New +$102K ﹤0.01% 9650

Other funds holding ADMA